Kathleen Laporte, Director at Precipio, holds 6.15K shares in Precipio (Ticker: PRPO), holds 971.83K shares in CERo Therapeutics Holdings (Ticker: CERO), holds 0.00 shares in 89bio (Ticker: ETNB). Most recently, Kathleen Laporte Sold ― shares of Precipio on Sep 10, 2025 for an estimated value of $123.41K.
Kathleen Laporte latest transaction was an Informative Sell of $123.41K.
What was Kathleen Laporte's most profitable transaction?
Kathleen Laporte’s most profitable transaction was an Informative Sell of ETNB stock on July 18, 2023. The return on the trade was 52.80%.
What is Kathleen Laporte's role in Precipio?
Kathleen Laporte's role in Precipio is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.